Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
2
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
0 competitors in Metastatic Castrate Resistant Prostate Cancer (mCRPC)
View Full LandscapeTarget Indication
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Clinical Trial
NCT06551324Last updated: 12/27/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Vaccines, Pneumococcal
Renal Transplantation
Diabetes Mellitus
Major Depressive Disorder
Complicated Intra-abdominal Infections